These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31234826)

  • 21. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
    Wang Z; Singh R; Miller BE; Tal-Singer R; Van Horn S; Tomsho L; Mackay A; Allinson JP; Webb AJ; Brookes AJ; George LM; Barker B; Kolsum U; Donnelly LE; Belchamber K; Barnes PJ; Singh D; Brightling CE; Donaldson GC; Wedzicha JA; Brown JR;
    Thorax; 2018 Apr; 73(4):331-338. PubMed ID: 29269441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
    Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sputum microbiota in severe asthma patients: Relationship to eosinophilic inflammation.
    Li N; Qiu R; Yang Z; Li J; Chung KF; Zhong N; Zhang Q
    Respir Med; 2017 Oct; 131():192-198. PubMed ID: 28947029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
    Kamada T; Kaneko M; Tomioka H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF; Zhao M; Li ZL; Song Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.
    Su L; Qiao Y; Luo J; Huang R; Li Z; Zhang H; Zhao H; Wang J; Xiao Y
    J Transl Med; 2022 Feb; 20(1):76. PubMed ID: 35123490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease.
    Tashiro H; Kurihara Y; Takahashi K; Sadamatsu H; Haraguchi T; Tajiri R; Takamori A; Kimura S; Sueoka-Aragane N
    BMC Pulm Med; 2020 Dec; 20(1):318. PubMed ID: 33287777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
    Pragman AA; Knutson KA; Gould TJ; Isaacson RE; Reilly CS; Wendt CH
    Respir Res; 2019 Jun; 20(1):114. PubMed ID: 31174538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study.
    Chen YF; Hou HH; Chien N; Lu KZ; Lin CH; Liao YC; Lor KL; Chien JY; Chen CM; Chen CY; Cheng SL; Wang HC; Hsueh PR; Yu CJ
    Respir Res; 2024 Aug; 25(1):308. PubMed ID: 39143556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study.
    Xiao W; Du LY; Mao B; Miao TW; Fu JJ
    BMJ Open; 2019 Nov; 9(11):e034592. PubMed ID: 31690612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease.
    Papi A; Romagnoli M; Baraldo S; Braccioni F; Guzzinati I; Saetta M; Ciaccia A; Fabbri LM
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1773-7. PubMed ID: 11069811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Richness of sputum microbiome in acute exacerbations of eosinophilic chronic obstructive pulmonary disease.
    Qi YJ; Sun XJ; Wang Z; Bin YF; Li YH; Zhong XN; Bai J; Deng JM; He ZY
    Chin Med J (Engl); 2020 Mar; 133(5):542-551. PubMed ID: 32053571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
    Wu Y; Luo Z; Liu C
    Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils.
    Eltboli O; Bafadhel M; Hollins F; Wright A; Hargadon B; Kulkarni N; Brightling C
    BMC Pulm Med; 2014 Jul; 14():112. PubMed ID: 25007795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
    Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
    Vedel-Krogh S; Nielsen SF; Lange P; Vestbo J; Nordestgaard BG
    Am J Respir Crit Care Med; 2016 May; 193(9):965-74. PubMed ID: 26641631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emphysematous Phenotype is Characterized by Low Blood Eosinophils: A Cross-Sectional Study.
    Papaioannou AI; Kostikas K; Papaporfyriou A; Angelakis L; Papathanasiou E; Hillas G; Mazioti A; Bakakos P; Koulouris N; Papiris S; Loukides S
    COPD; 2017 Dec; 14(6):635-640. PubMed ID: 29099646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
    Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
    J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung microbiome dynamics in COPD exacerbations.
    Wang Z; Bafadhel M; Haldar K; Spivak A; Mayhew D; Miller BE; Tal-Singer R; Johnston SL; Ramsheh MY; Barer MR; Brightling CE; Brown JR
    Eur Respir J; 2016 Apr; 47(4):1082-92. PubMed ID: 26917613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Airflow limitation severity and post-operative pulmonary complications following extra-pulmonary surgery in COPD patients.
    Shin B; Lee H; Kang D; Jeong BH; Kang HK; Chon HR; Koh WJ; Chung MP; Guallar E; Cho J; Park HY
    Respirology; 2017 Jul; 22(5):935-941. PubMed ID: 28117553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.